Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy

Digestive Diseases and Sciences

Volumn 45, Issue 10, 2000, Pages 2036-2043

  Hall III, R P ^a   Smith, A D ^a   Streilein, R D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dermatitis herpetiformis; Gluten sensitive enteropathy; Mucosal immunity; T cell

Indexed keywords

ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; GAMMA INTERFERON; GLUTEN; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATITIS HERPETIFORMIS; DIET; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; CELIAC DISEASE; CELL LINE; DERMATITIS HERPETIFORMIS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0033740318     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005512513007     Document Type: Article

References (33)

1. Testing of autoimmune therapy begins
2. Oral tolerance for the treatment of autoimmune diseases
3. Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance
4. Oral Tolerance: Feeding autoantigens can exacerbate rather than ameliorate autoimmune disease
5. Interactions between dietary proteins and the human system: Implications for oral tolerance and food-related diseases
6. Dermatitis herpetiformis
7. Long term follow-up of dermatitis herpetiformis with and without dietary withdrawal
8. Gluten challenge in dermatitis herpetiformis
9. The small intestinal mucosa in dermatitis herpetiformis
10. Coeliac sprue
11. Celiac disease
12. Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease
13. Absence of cutaneous IgA in coeliac disease without dermatitis herpetiformis
14. Activated T lymphocytes in the coeliac lesion: Non-proliferative activation (CD25) of CD4+ α/β cells in the lamina propria but proliferation (Ki-67) of α/β and gamma/delta cells in the epithelium
15. Intestinal gamma/delta receptor-bearing T lymphocytes in coeliac disease and inflammatory bowel disease in children. Constant increase in coeliac disease
16. Preferential activation of CD4 T lymphocytes in the lamina propria of gluten-sensitive enteropathy
17. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma
18. Detection of intracellular cytokines by flow cytometry
19. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions
20. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation
21. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge
22. Increased proinflammatory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge
23. Raised proinflammatory cytokines interleukin 6 and tumour necrosis factor a in coeliac disease mucosa detected by immunohistochemistry
24. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease
25. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cy tokines with Th1 or Th0 profile dominated by interferon gamma
26. Majority of gliadin-specific T-ceil clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4
27. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody
28. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers
29. IL- 4 directly modulates function of a model human intestinal epithelium
30. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice
31. IL- 4 is an endogenous inhibitor of neutrophil influx and subsequent pathology in acute antibody mediated inflammation
32. Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type
33. Differential antigenic stimulation influences cytokine production patterns in T cells and CD4+ subpopulations